$CYCC
Cyclacel Pharmaceuticals, Inc.

2012 Q2 Form 10-Q Financial Statement

#000110465912057847 Filed on August 14, 2012

View on sec.gov

Income Statement

Concept 2012 Q2 2011 Q4 2011 Q2
Revenue $26.00K $0.00 $168.0K
YoY Change -84.52% -100.0% 40.0%
Cost Of Revenue $72.00K
YoY Change -20.0%
Gross Profit $96.00K
YoY Change 220.0%
Gross Profit Margin 57.14%
Selling, General & Admin $2.121M $1.410M $2.034M
YoY Change 4.28% -30.2% -34.17%
% of Gross Profit 2118.75%
Research & Development $1.717M $2.200M $1.859M
YoY Change -7.64% 51.72% 40.83%
% of Gross Profit 1936.46%
Depreciation & Amortization $10.00K -$10.00K $80.00K
YoY Change -87.5% -109.09% -27.27%
% of Gross Profit 83.33%
Operating Expenses $3.838M $3.610M $3.893M
YoY Change -1.41% 4.34% -11.92%
Operating Profit -$3.812M -$3.797M
YoY Change 0.4% -13.51%
Interest Expense $270.0K $0.00 -$10.00K
YoY Change -2800.0% -100.0% -80.0%
% of Operating Profit
Other Income/Expense, Net $306.0K -$30.00K $119.0K
YoY Change 157.14% -127.27% -55.93%
Pretax Income -$3.506M -$3.640M -$3.678M
YoY Change -4.68% 9.31% -11.59%
Income Tax -$127.0K -$120.0K -$126.0K
% Of Pretax Income
Net Earnings -$3.577M -$3.660M -$3.552M
YoY Change 0.7% 15.46% -9.62%
Net Earnings / Revenue -13757.69% -2114.29%
Basic Earnings Per Share -$0.45
Diluted Earnings Per Share -$0.45 -$91.50M -$118.3M
COMMON SHARES
Basic Shares Outstanding 8.428M shares 46.58M shares
Diluted Shares Outstanding 8.428M shares

Balance Sheet

Concept 2012 Q2 2011 Q4 2011 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $19.96M $24.45M $20.61M
YoY Change -3.15% -17.12% 5.48%
Cash & Equivalents $19.96M $24.45M $20.61M
Short-Term Investments
Other Short-Term Assets $113.0K $208.0K $690.0K
YoY Change -83.62% -66.45% 7.81%
Inventory $50.00K $150.0K
Prepaid Expenses $486.0K $317.0K
Receivables $45.00K $116.0K
Other Receivables $850.0K
Total Short-Term Assets $21.65M $25.83M $22.45M
YoY Change -3.55% -16.81% 4.37%
LONG-TERM ASSETS
Property, Plant & Equipment $150.0K $167.0K $250.0K
YoY Change -40.0% 0.0% -59.02%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change
Total Long-Term Assets $147.0K $167.0K $250.0K
YoY Change -41.2% -59.07% -68.75%
TOTAL ASSETS
Total Short-Term Assets $21.65M $25.83M $22.45M
Total Long-Term Assets $147.0K $167.0K $250.0K
Total Assets $21.80M $26.00M $22.70M
YoY Change -3.96% -17.36% 1.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.540M $1.717M $1.100M
YoY Change 40.0% -0.35% -29.03%
Accrued Expenses $4.174M $4.183M $3.340M
YoY Change 24.97% 1.23% -2.91%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.750M $6.498M $6.040M
YoY Change 11.75% -0.57% -25.98%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $6.750M $6.498M $6.040M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $6.750M $6.498M $6.040M
YoY Change 11.75% -0.57% -25.98%
SHAREHOLDERS EQUITY
Retained Earnings -$257.1M
YoY Change 6.3%
Common Stock $8.000K
YoY Change -82.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $15.06M $19.50M $16.66M
YoY Change
Total Liabilities & Shareholders Equity $21.80M $26.00M $22.70M
YoY Change -3.96% -17.36% 1.75%

Cashflow Statement

Concept 2012 Q2 2011 Q4 2011 Q2
OPERATING ACTIVITIES
Net Income -$3.577M -$3.660M -$3.552M
YoY Change 0.7% 15.46% -9.62%
Depreciation, Depletion And Amortization $10.00K -$10.00K $80.00K
YoY Change -87.5% -109.09% -27.27%
Cash From Operating Activities -$3.710M -$3.260M -$4.570M
YoY Change -18.82% -12.83% -8.78%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $40.00K $10.00K $0.00
YoY Change
Cash From Investing Activities $30.00K $10.00K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -30.00K 10.00K -180.0K
YoY Change -83.33% -99.93% -169.23%
NET CHANGE
Cash From Operating Activities -3.710M -3.260M -4.570M
Cash From Investing Activities 30.00K 10.00K 0.000
Cash From Financing Activities -30.00K 10.00K -180.0K
Net Change In Cash -3.710M -3.240M -4.750M
YoY Change -21.89% -131.21% 0.0%
FREE CASH FLOW
Cash From Operating Activities -$3.710M -$3.260M -$4.570M
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$3.710M -$3.260M -$4.570M
YoY Change -18.82% -12.83% -8.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q2 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
1639000 USD
CY2011Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
1200000 USD
CY2012Q2 us-gaap Other Assets Current
OtherAssetsCurrent
113000 USD
CY2012Q2 us-gaap Deposits Assets Current
DepositsAssetsCurrent
153000 USD
CY2012Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
45000 USD
CY2012Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
486000 USD
CY2012Q2 us-gaap Deferred Income Taxes And Other Tax Receivable Current
DeferredIncomeTaxesAndOtherTaxReceivableCurrent
842000 USD
CY2011Q4 us-gaap Other Assets Current
OtherAssetsCurrent
209000 USD
CY2011Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
13000 USD
CY2011Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
116000 USD
CY2011Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
321000 USD
CY2011Q4 us-gaap Deferred Income Taxes And Other Tax Receivable Current
DeferredIncomeTaxesAndOtherTaxReceivableCurrent
541000 USD
CY2012Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4174000 USD
CY2012Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
21000 USD
CY2012Q2 cycc Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
2923000 USD
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4664000 USD
CY2011Q4 cycc Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
3471000 USD
CY2012Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
3.28
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19964000 USD
CY2011Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20351602 shares
CY2011Q4 us-gaap Deferred Revenue
DeferredRevenue
100000 USD
CY2011Q4 cycc Deferred Cost Of Goods Sold
DeferredCostOfGoodsSold
22000 USD
CY2012Q2 cycc Deferred Cost Of Goods Sold
DeferredCostOfGoodsSold
19000 USD
CY2012Q2 cycc Deferred Grant Revenue
DeferredGrantRevenue
48000 USD
CY2012Q2 us-gaap Number Of Countries In Which Entity Operates
NumberOfCountriesInWhichEntityOperates
2 area
CY2012Q2 us-gaap Deferred Revenue
DeferredRevenue
100000 USD
CY2012Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1028000 USD
CY2011Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
71000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24449000 USD
CY2011Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
182000 USD
CY2011Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1200000 USD
CY2011Q4 us-gaap Assets Current
AssetsCurrent
25831000 USD
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
167000 USD
CY2011Q4 us-gaap Assets
Assets
25998000 USD
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1763000 USD
CY2011Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
71000 USD
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6498000 USD
CY2011Q4 us-gaap Liabilities
Liabilities
6498000 USD
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
1000 USD
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
54000 USD
CY2011Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
276452000 USD
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
57000 USD
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-257064000 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
19500000 USD
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25998000 USD
CY2012Q2 us-gaap Assets Current
AssetsCurrent
21653000 USD
CY2012Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1007000 USD
CY2012Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21802000 USD
CY2012Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001 shares
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001 shares
CY2012Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2011Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1213142 shares
CY2011Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1213142 shares
CY2012Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1213142 shares
CY2012Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1213142 shares
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59001229 shares
CY2012Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
59001229 shares
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-3577000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
360000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
360000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
178000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4939000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3840000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-4098000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
13737000 USD
us-gaap Interest Expense
InterestExpense
4677000 USD
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54220458 shares
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54220458 shares
CY2012Q2 us-gaap Revenue From Grants
RevenueFromGrants
26000 USD
CY2011Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
168000 USD
CY2011Q2 us-gaap Sales Revenue Net
SalesRevenueNet
168000 USD
CY2011Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
72000 USD
CY2011Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1859000 USD
CY2011Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2034000 USD
CY2011Q2 us-gaap Costs And Expenses
CostsAndExpenses
3965000 USD
CY2011Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3797000 USD
CY2011Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
125000 USD
CY2011Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-19000 USD
CY2011Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
13000 USD
CY2011Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
119000 USD
CY2011Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3678000 USD
CY2011Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-126000 USD
CY2011Q2 us-gaap Net Income Loss
NetIncomeLoss
-3552000 USD
CY2011Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3734000 USD
CY2011Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2011Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46582915 shares
us-gaap Costs And Expenses
CostsAndExpenses
8957000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-8597000 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
203000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-87000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
24000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
140000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-8457000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-317000 USD
us-gaap Net Income Loss
NetIncomeLoss
-8140000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8504000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.18
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46577577 shares
us-gaap License And Services Revenue
LicenseAndServicesRevenue
3100000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
3302000 USD
us-gaap Revenue From Grants
RevenueFromGrants
3674000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
10076000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
1935000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
188863000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
93833000 USD
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
7934000 USD
us-gaap Other Restructuring Costs
OtherRestructuringCosts
2634000 USD
us-gaap Costs And Expenses
CostsAndExpenses
295199000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-285123000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
-3550000 USD
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
6377000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6303000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-18739000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
225000 USD
us-gaap Net Income Loss
NetIncomeLoss
-260081000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-305740000 USD
CY2011Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3521000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8132000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-260003000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
172000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-21000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
455000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
279000 USD
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
-482000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-8456000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-80000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3000 USD
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
364000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-441000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
16000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-8881000 USD
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
11000 USD
us-gaap Accretion Expense
AccretionExpense
100000 USD
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
-2297000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
886000 USD
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
221000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-7747000 USD
us-gaap Recognition Of Deferred Revenue
RecognitionOfDeferredRevenue
98000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-38000 USD
us-gaap Payments For Restructuring
PaymentsForRestructuring
-1779000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2517000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-220595000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
3763000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8847000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
156657000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
162729000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-6313000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
3719000 USD
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
121678000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
94557000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
207000 USD
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
1898000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
455000 USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
414000 USD
us-gaap Proceeds From Loans
ProceedsFromLoans
9103000 USD
us-gaap Loans And Leases Receivable Related Parties Collections
LoansAndLeasesReceivableRelatedPartiesCollections
-1645000 USD
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
17915000 USD
us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
1951000 USD
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
18207000 USD
us-gaap Interest Paid Net
InterestPaidNet
-1914000 USD
us-gaap Noncash Or Part Noncash Acquisition Other Liabilities Assumed1
NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1
1122000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29495000 USD
CY2011Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20614000 USD
CY2012Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
59007990 shares
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3564000 USD

Files In Submission

Name View Source Status
0001104659-12-057847-index-headers.html Edgar Link pending
0001104659-12-057847-index.html Edgar Link pending
0001104659-12-057847.txt Edgar Link pending
0001104659-12-057847-xbrl.zip Edgar Link pending
a12-14026_110q.htm Edgar Link pending
a12-14026_1ex31d1.htm Edgar Link pending
a12-14026_1ex31d2.htm Edgar Link pending
a12-14026_1ex32d1.htm Edgar Link pending
a12-14026_1ex32d2.htm Edgar Link pending
cycc-20120630.xml Edgar Link completed
cycc-20120630.xsd Edgar Link pending
cycc-20120630_cal.xml Edgar Link unprocessable
cycc-20120630_def.xml Edgar Link unprocessable
cycc-20120630_lab.xml Edgar Link unprocessable
cycc-20120630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending